Femring
Product Images NDC 54868-6030

13 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Femring (NDC 54868-6030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of the active ingredient in Femring, depicted with a steroid backbone featuring hydroxyl and methyl groups, consistent with the structure of estradiol acetate.*
FDA Label Image

Image Of Diagram 1a (Diagram 1a)

Image Of Diagram 1a (Diagram 1a)
An instructional illustration showing a woman lying on her back with her knees bent and feet flat on the surface, supporting her upper body with a pillow behind her head. She is wearing a red top and appears to be demonstrating a relaxed position, possibly related to product usage or administration for Femring.*
FDA Label Image

Image Of Diagram 1b (Diagram 1b)

Image Of Diagram 1b (Diagram 1b)
An illustrated instructional diagram showing a woman standing and placing one foot on the edge of a bathtub. She is bending slightly forward, with one hand resting on her elevated thigh and the other hand on her hip. The image appears to demonstrate a physical action or exercise, possibly related to bathing or personal hygiene.*
FDA Label Image

Image Of Diagram 2 (Diagram 2)

Image Of Diagram 2 (Diagram 2)
An instructional illustration showing a hand holding a Femring vaginal ring, demonstrating its flexible, circular shape likely intended for insertion. The image highlights the ring's design allowing it to be compressed for ease of use.*
FDA Label Image

Image Of Digram 3 (Diagram 3)

Image Of Digram 3 (Diagram 3)
An illustration showing a hand positioned near the vaginal area, demonstrating the insertion of a ring-shaped device, likely for vaginal use. The image is framed in a circular pink border, emphasizing the location and method of insertion.*
FDA Label Image

Image Of Diagram 4 (Diagram 4)

Image Of Diagram 4 (Diagram 4)
An instructional illustration showing the correct insertion of a vaginal ring. The image depicts a hand placing the ring into the vagina, demonstrating the proper placement technique for the Femring vaginal ring.*
FDA Label Image

Image Of Diagram 5 (Diagram 5)

Image Of Diagram 5 (Diagram 5)
An instructional diagram illustrating the proper insertion of Femring vaginal ring. The image shows a cross-sectional view of the female pelvic region with a hand inserting the ring into the vaginal canal, highlighting correct placement.*
FDA Label Image

Image Of Diagram 6 (Diagram 6)

Image Of Diagram 6 (Diagram 6)
An anatomical illustration showing a sagittal view of the female pelvic area with a ring device positioned in the vaginal canal, highlighting the placement of the Femring product.*
FDA Label Image

Image Of Diagram 7 (Diagram 7)

Image Of Diagram 7 (Diagram 7)
An instructional illustration showing the insertion of a vaginal ring. The image depicts a hand placing the ring inside the vagina, with anatomical outlines of the pelvic region for reference. The diagram is encircled by a pink border.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A pharmacokinetic line graph showing serum estradiol concentration (pg/mL) over time (weeks), illustrating changes with a sharp peak at the start and another spike at around week 13, with a smaller inset graph showing concentration changes over hours within 24 hours.*
FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
A labeled anatomical diagram highlighting the female pelvic organs, showing the uterus, bladder, vagina, and anus in a sagittal cross-section view.*
FDA Label Image

Image Of Package Label (Package Label)

Image Of Package Label (Package Label)
Packaging label for Femring 0.1 mg vaginal ring by Physicians Total Care, Inc. The label lists the NDC as 54868-6030, includes lot number 0000, and an expiration date of 01/60. It also mentions manufacturing by Warner Chilcott UK Ltd in Loughborough, U.K. A barcode is present at the bottom of the label.*
FDA Label Image

Image Of Wc Name (Wc Name)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.